Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
European Journal of Dermatology : EJD
|
October 27, 2022
Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trials
Andreas Wollenberg, Peter Lio, Elise Kleyn, et al.
Dermatology and Therapy
|
November 12, 2024
Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study
Melinda Gooderham, Emma Guttman-Yassky, Ken Igawa, et al.
The Journal of Investigative Dermatology
|
October 23, 2020
Inverse Correlation of TRIM32 and Protein Kinase C ζ in T Helper Type 2-Biased Inflammation
Zhiping Wang, Yeon Jung Yoo, Rachel De La Torre, et al.
Dermatologic Therapy
|
October 21, 2022
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes
Eric Simpson, April Armstrong, Mark Boguniewicz, et al.
Dermatology and Therapy
|
September 22, 2017
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Andreas Kuznik, Gaëlle Bégo-Le-Bagousse, Laurent Eckert, et al.
BMC Dermatology
|
November 7, 2019
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis
Eric Simpson, Laurent Eckert, Abhijit Gadkari, et al.
Cytokine
|
November 6, 2020
Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes
Benjamin Ehst, Zhiping Wang, Justin Leitenberger, et al.
The Journal of Dermatological Treatment
|
March 12, 2026
Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years
Eric Simpson, Tilo Biedermann, Leon Kircik, et al.
The Journal of Allergy and Clinical Immunology
|
October 6, 2014
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
Jochen Schmitt, Phyllis I Spuls, Kim S Thomas, et al.
Dermatology and Therapy
|
July 22, 2023
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry
Jonathan I Silverberg, Vivian Y Shi, Andrew Alexis, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
European Journal of Dermatology : EJD
|
October 27, 2022
Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trials
Andreas Wollenberg, Peter Lio, Elise Kleyn, et al.
Dermatology and Therapy
|
November 12, 2024
Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study
Melinda Gooderham, Emma Guttman-Yassky, Ken Igawa, et al.
The Journal of Investigative Dermatology
|
October 23, 2020
Inverse Correlation of TRIM32 and Protein Kinase C ζ in T Helper Type 2-Biased Inflammation
Zhiping Wang, Yeon Jung Yoo, Rachel De La Torre, et al.
Dermatologic Therapy
|
October 21, 2022
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes
Eric Simpson, April Armstrong, Mark Boguniewicz, et al.
Dermatology and Therapy
|
September 22, 2017
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Andreas Kuznik, Gaëlle Bégo-Le-Bagousse, Laurent Eckert, et al.
BMC Dermatology
|
November 7, 2019
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis
Eric Simpson, Laurent Eckert, Abhijit Gadkari, et al.
Cytokine
|
November 6, 2020
Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes
Benjamin Ehst, Zhiping Wang, Justin Leitenberger, et al.
The Journal of Dermatological Treatment
|
March 12, 2026
Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years
Eric Simpson, Tilo Biedermann, Leon Kircik, et al.
The Journal of Allergy and Clinical Immunology
|
October 6, 2014
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
Jochen Schmitt, Phyllis I Spuls, Kim S Thomas, et al.
Dermatology and Therapy
|
July 22, 2023
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry
Jonathan I Silverberg, Vivian Y Shi, Andrew Alexis, et al.
Page
of 8